World’s top-selling drug going off patent means big bucks for middlemen

Hasan

New member
World’s top-selling drug going off patent means big bucks for middlemen As AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be the middlemen.
 
Üst